Skip to main content
SpringerLink
Log in

QOL measurements: an important part of Parkinson’s disease assessment

  • Drug economics and quality of life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jenkinson C, Fitzpatrick R, Peto V Health-related quality-of-life measurement in patients with Parkinson’s disease. Pharmacoeconomics 1999 Feb; 15: 157–65

    Article  PubMed  CAS  Google Scholar 

  2. Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–42

    Article  PubMed  CAS  Google Scholar 

  3. Hely M, Chey T, Wilson A, et al. Reliability of the Columbia scale for assessing signs of Parkinson’s disease. Mov Disord 1993; 8: 466–72

    Article  PubMed  CAS  Google Scholar 

  4. Fahn S, Elton RL, the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden M, Goldstein M, editors. Recent developments in Parkinson’s disease. Vol 2. New York (NY): MacMillan, 1987: 153–63

    Google Scholar 

  5. Longstreth W, Nelson L, Linde M, et al. Utility of the Sickness Impact Profile in Parkinson’s disease. J Geriatr Psychiatry Neurol 1992: 5: 142–8

    PubMed  Google Scholar 

  6. Jenkinson C, Peto V, Fitzpatrick R, et al. Self-reported functioning and well-being in patients with Parkinson’s disease: a comparison of the short-form health survey (SF-36) and the Parkinson’s disease questionnaire (PDQ-39). Age Ageing 1995; 24: 505–9

    Article  PubMed  CAS  Google Scholar 

  7. Martinez-Martin P, Frades Payo B, the Grupo Centro for Movement Disorders. Quality of life in patients with Parkinson’s disease: validation study of the PDQ-39 Spanish version. J Neurol 1998; 245Suppl. 1: S34–8

    Article  PubMed  Google Scholar 

  8. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development, and final revision of a health status measure. Med Care 1981; 19: 787–805

    Article  PubMed  CAS  Google Scholar 

  9. Hunt S, McEwen J, McKenna S. Measuring health status. London: Croom Helm, 1986

    Google Scholar 

  10. Ware J, Sherbourne C. The MOS 36-Item Short-Form Health Survey 1: conceptual framework and item selection. Med Care 1992; 30: 473–83

    Article  PubMed  Google Scholar 

  11. De Boer AGEM, Wijker W, Speelman JD, et al. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61: 70–4

    Article  PubMed  Google Scholar 

  12. Jenkinson G, Fitzpatrick R, Peto V. The Parkinson’s Disease Questionnaire: user manual for PDQ-39, PDQ-8 and PDQ Summary Index. Oxford: Health Services Research Unit, 1998

    Google Scholar 

  13. Patrick D, Peach H. Disablement in the community. Oxford: Oxford University Press, 1989

    Google Scholar 

  14. Welburn P, Walker S. Assessment of quality-of-life in Parkinson’s disease. In: Teeling Smith G, editor. Measuring health: a practical approach. Chichester: John Wiley, 1988: 89–108

    Google Scholar 

  15. Mercer B. A randomized study of the efficacy of the PROPATH program for patients with Parkinson’s disease. Arch Neurol 1996: 53; 881–4

    Article  PubMed  CAS  Google Scholar 

  16. Pahwa R, Lyons K, McGuire D, et al. Comparisons of standard Carbidopa-levodopa and sustained release Carbidopa-levodopa in Parkinson’s disease: pharmacokinetic and quality-of-life measures. Mov Disord 1997; 12: 677–81

    Article  PubMed  CAS  Google Scholar 

  17. Fitzpatrick R, Peto V, Jenkinson C, et al. Health-related quality of life in Parkinson’s disease: a study of out-patient clinic attenders. Mov Disord 1997; 6: 297–34

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

QOL measurements: an important part of Parkinson’s disease assessment. Drugs Ther. Perspect 15, 13–16 (2000). https://doi.org/10.2165/00042310-200015070-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200015070-00005

Keywords

Search

Navigation